| Product Name | MF | CAS | Details |
|---|
| (2R)-2-(Bromomethyl)oxolane | C5H9BrO | 57203-02-8 | Details |
| Enalaprilat dihydrate | C18H26N2O6 | 84680-54-6 | Details |
| Ethyl 4-(2-fluorophenyl)piperazine-1-carboxylate | C13H17FN2O2 | 140616-29-1 | Details |
| RAPGEF5 antibody | Details |
| 5-(Prop-2-enamido)pentanoic acid | C8H13NO3 | 71325-54-7 | Details |
| RNF44 Blocking Peptide | Details |
| 2-Amino-1-phenylbutan-1-ol | C10H15NO | 5897-76-7 | Details |
| 3-Propyl-cyclobutanecarboxylic acid | C8H14O2 | 66016-17-9 | Details |
| Tyr-Leptin (26-39) (human) | C80H137N19O25 | 309247-25-4 | Details |
| Ethyl 2-(2-ethoxy-2-oxoacetamido)-4,5-dimethylthiophene-3-carboxylate | C13H17NO5S | 67318-08-5 | Details |
| NANOGP8 antibody | Details |
| 3-Ethylaminopropionitrile | C5H10N2 | 21539-47-9 | Details |
| (R)-1-(4-Bromo-2-chlorophenyl)ethan-1-amine hydrochloride | C8H10BrCl2N | 2554381-12-1 | Details |
| N-Benzyl-N-methylthiourea | C9H12N2S | 53393-11-6 | Details |
| 5-(6-Aminopyridin-3-yl)furan-2-carboxylic acid | C10H8N2O3 | 893729-54-9 | Details |
| 2-Nitro-4-(trifluoromethyl)benzaldehyde | C8H4F3NO3 | 109466-87-7 | Details |
| Ac-GAQGHTVEK-OH | Details |
| Kamebakaurin | C20H30O5 | 73981-34-7 | Details |
| Ruxolitinib phosphate | C17H21N6O4P | 1092939-17-7 | Details |
| 4-Iodo-1-tritylimidazole | C22H17IN2 | 96797-15-8 | Details |
| (2-Methoxyphenyl)acetone oxime | C10H13NO2 | 43021-97-2 | Details |
| 1-(4-Nitrophenyl)piperidin-4-one | C11H12N2O3 | 23499-01-6 | Details |
| 1,3-Bis(bromomethyl)-5-methoxybenzene | C9H10Br2O | 19254-79-6 | Details |
| (S)-(+)-a-Fluoromethylhistidine dihydrochloride | C7H11ClFN3O2 | 81839-27-2 | Details |
| 1-(2-Bromo-3-hydroxyphenyl)ethan-1-one | C8H7BrO2 | 1232407-20-3 | Details |
| 4-(2-Thienyl)butyric acid | C8H10O2S | 4653-11-6 | Details |
| 4-Chloro-1,3-thiazole-2-carboxylic acid | C4H2ClNO2S | 1211521-70-8 | Details |
| 3-(1-Ethyl-1H-pyrazol-4-yl)-1-methyl-1H-pyrazole-4-carboxylic acid | C10H12N4O2 | 1249995-53-6 | Details |
| GPR50 antibody | Details |
| (2S,3aS,6aR)-1-[(2R)-2-{[(2R)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]-octahydrocyclopenta[b]pyrrole-2-carboxylic acid | C23H32N2O5 | 1807941-03-2 | Details |
| 1-(2,4-Difluorophenyl)-5-methyl-1H-pyrazole-3-carboxylic acid | C11H8F2N2O2 | 1274470-76-6 | Details |
| (2Z)-(2,4-Dioxo-1,3-thiazolidin-5-ylidene)acetic acid | C5H3NO4S | 5374-29-8 | Details |
| (3R)-4-Cyclohexyl-3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)butanoic acid | C25H29NO4 | 2219354-02-4 | Details |
| Homocapsaicin II | C19H29NO3 | 71240-51-2 | Details |
| ARMC6 antibody | Details |
| 3-[3-(Aminomethyl)phenyl]benzoic acid hydrochloride | 2243513-91-7 | Details |
| Sesamolin | C20H18O7 | 526-07-8 | Details |
| 1-Pyrrolidinecarboxylic acid, 3-amino-4-(hydroxymethyl)-, 1,1-dimethylethyl ester | C10H20N2O3 | 1184918-34-0 | Details |
| 2-(4-Chlorophenyl)-3-methylbutan-1-amine | C11H16ClN | 95349-14-7 | Details |
| Echinatine N-oxide | C15H25NO6 | 20267-93-0 | Details |
| Riboflavin 5'-phosphate sodium | C17H22N4NaO9P | 130-40-5 | Details |
| Ethyl 2-methyl-3-(4-nitrophenyl)prop-2-enoate | C12H13NO4 | 53618-29-4 | Details |
| Boc-Asn-Gly-OEt | C13H23N3O6 | 211056-85-8 | Details |
| OCIAD2 antibody | Details |
| 4-(Azetidin-3-yl)phenol hydrochloride | C9H12ClNO | 7606-33-9 | Details |
| Nesfatin-1 (30-59) (mouse, rat) trifluoroacetate salt | Details |
| 2,2'-(Azanediylbis(ethane-2,1-diyl))bis(1H-benzo[de]isoquinoline-1,3(2H)-dione) | C28H21N3O4 | 281224-40-6 | Details |
| 2-(3,4-Dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethylamino]-2-propan-2-ylpentanenitrile hydrochloride | C26H37ClN2O4 | 67812-42-4 | Details |
| Gestodene | C21H26O2 | 60282-87-3 | Details |
| tert-Butyl 5-hydroxy-2-azabicyclo[2.2.2]octane-2-carboxylate | C12H21NO3 | 750634-09-4 | Details |
| 4-(Chloromethyl)-3-methyl-1-(propan-2-yl)-1H-pyrazole hydrochloride | 2126160-24-3 | Details |
| 2-Bromo-6-(bromomethyl)-3-fluoropyridine | C6H4Br2FN | 1227574-68-6 | Details |
| CD3D antibody | Details |
| 5-Amino-1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-1,2,3-triazole-4-carboxamide | C9H19N5O2Si | 1803601-42-4 | Details |
| 1-Chloro-2-ethynyl-4-(trifluoromethyl)benzene | C9H4ClF3 | 148258-94-0 | Details |
| 4-Amino-N-(3,4-dimethoxyphenyl)benzene-1-sulfonamide | C14H16N2O4S | 438003-24-8 | Details |
| 5'-O-DMT-thymidine-3'-succinyl CPG 1400 ? | Details |
| 6-Amino-1H-indazole-3-carboxylic acid | C8H7N3O2 | 885519-22-2 | Details |
| 4-(2,2-Dichlorocyclopropyl)butan-2-one | C7H10Cl2O | 77237-13-9 | Details |
| 4-Methoxy-2-[2-(propan-2-yloxy)ethoxy]benzoic acid | C13H18O5 | 1285204-24-1 | Details |
| Natalizumab LC46-58 KGN deimmunised | Details |
| [5-(Morpholine-4-sulfonyl)-thiophen-2-yl]-acetic acid | C10H13NO5S2 | 309282-76-6 | Details |
| 2-(Dimethylamino)-1,3-benzoxazole-6-carboxylic acid | C10H10N2O3 | 1393746-53-6 | Details |
| Polystyrene M NH2 | Details |
| SEPHS1 Blocking Peptide | Details |
| IDI2 protein (His tag) | Details |
| 1-(4-Methoxyphenyl)-3-methylbutan-1-one | C12H16O2 | 82938-20-3 | Details |
| Ambuic acid | C19H26O6 | 340774-69-8 | Details |
| Nα-tert-butoxycarbonyl-nε-tetradecanoyl-L-lysine | C25H48N2O5 | 2173052-71-4 | Details |
| (3-Isopropyl-[1,2,4]oxadiazol-5-yl)-acetonitrile | C7H9N3O | 1239752-36-3 | Details |
| (1S)-1-(4-Bromothiophen-2-yl)-2,2,2-trifluoroethan-1-ol | C6H4BrF3OS | 1423040-75-8 | Details |
| H-VEIIATMK-OH | Details |
| 1-Cyclohexyl-1H-1,2,4-triazol-3-amine | C8H14N4 | 1179738-24-9 | Details |
| Ethyl (4R)-4-{[(tert-butoxy)carbonyl]amino}-3-hydroxypentanoate | C12H23NO5 | 1965266-29-8 | Details |
| PCT monoclonal antibody | Details |
| RANK antibody (biotin) | Details |
| N-[1-(1-Benzofuran-2-yl)ethyl]-2-chloropropanamide | C13H14ClNO2 | 1154010-39-5 | Details |
| 4-(3-Methoxyphenyl)-1,2,3,6-tetrahydropyridine | C12H15NO | 194669-46-0 | Details |
| H-IFYNQQSHYDGTTGK-OH | Details |
| Ethyl 4-benzyl-3,5-dioxo-4-azatetracyclo[5.3.2.02,?.0?,1?]dodec-11-ene-9-carboxylate | C21H21NO4 | 1803601-47-9 | Details |
| GJE1 antibody | Details |
| (1R,2R)-2-Fluorocyclohexanamine hydrochloride | C6H13ClFN | 1820580-16-2 | Details |
| [4-(Prop-2-yne-1-sulfonyl)phenyl]methanol | C10H10O3S | 1795330-63-0 | Details |
| 2-(Dimethyl-1,2-oxazol-4-yl)propan-1-amine | C8H14N2O | 893641-20-8 | Details |
| 2-(1,3-Dioxaindan-5-yl)propanoic acid | C10H10O4 | 25476-44-2 | Details |
| H-DRAHYNI-OH | Details |
| 2-(Piperidin-4-Yloxy)Pyrimidine Dihydrochloride | C9H14ClN3O | 950649-19-1 | Details |
| Acetyl-(Leu28·31)-Neuropeptide Y (24-36) trifluoroacetate salt | C81H131N27O19 | 155709-24-3 | Details |
| 4-Nitrophenyl 3-O-(b-D-glucopyranosyl)-a-D-glucopyranoside | C18H25NO13 | Details |
| 2-Methoxy-N,5-dimethylaniline hydrochloride | C9H14ClNO | 2375270-94-1 | Details |
| N-[(1,3-Dioxaindan-5-yl)methyl]aminosulfonamide | C8H10N2O4S | 1098609-12-1 | Details |
| [(2,2-Difluoro-1,3-dioxaindan-5-yl)methyl](methyl)amine hydrochloride | C9H10ClF2NO2 | 1909316-10-4 | Details |
| PRUNE antibody | Details |
| 4-(tert-Butyl)piperidin-4-ol hydrochloride | C9H20ClNO | 22093-42-1 | Details |
| 4-Methyl-2-(piperidin-2-yl)cyclohexan-1-ol | C12H23NO | 1559114-54-3 | Details |
| 2-(Pyrrolidin-3-yl)acetamide trifluoroacetate | C8H13F3N2O3 | 1989672-63-0 | Details |
| H-9 hydrochloride | C11H14ClN3O2S | 116970-50-4 | Details |
| (2-Phenylcyclopropyl)methanamine hydrochloride | C10H14ClN | 90874-42-3 | Details |
| EPX Blocking Peptide | Details |
| (2R)-4-Carbamoyl-2-decanamidobutanoic acid | C15H28N2O4 | 1354940-99-0 | Details |
| Product Total： Product Page： | ||||
| 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 | ||||